Jacalyn M. Duffin and Jon Pipitone

What’s up (or down) with drug shortages?

• With complaints and fears swirling around COVID-19 vaccine supply, we take up our devices once again to report on drug shortages in Canada. When

Opinion | BY JACALYN M. DUFFIN AND JON PIPITONE | February 8, 2021

What’s up (or down) with drug shortages?

Opinion | BY JACALYN M. DUFFIN AND JON PIPITONE | February 8, 2021

• With complaints and fears swirling around COVID-19 vaccine supply, we take up our devices once again to report on drug shortages in Canada. When

What’s up (or down) with drug shortages?

Opinion | BY JACALYN M. DUFFIN AND JON PIPITONE | February 8, 2021

• With complaints and fears swirling around COVID-19 vaccine supply, we take up our devices once again to report on drug shortages in Canada. When

Medicine shortages in light of COVID-19: a wake-up call for drug security

• KINGSTON, ONT.—Recently, the global number of shortages, pending and actual, is increasing—especially in the United States—and coronavirus is to blame. In Canada, we are

Opinion | BY JACALYN M. DUFFIN AND JON PIPITONE | April 27, 2020

Medicine shortages in light of COVID-19: a wake-up call for drug security

Opinion | BY JACALYN M. DUFFIN AND JON PIPITONE | April 27, 2020

• KINGSTON, ONT.—Recently, the global number of shortages, pending and actual, is increasing—especially in the United States—and coronavirus is to blame. In Canada, we are

Medicine shortages in light of COVID-19: a wake-up call for drug security

Opinion | BY JACALYN M. DUFFIN AND JON PIPITONE | April 27, 2020

• KINGSTON, ONT.—Recently, the global number of shortages, pending and actual, is increasing—especially in the United States—and coronavirus is to blame. In Canada, we are

More Stories